Concepedia

N. Ngoi

NN

1

Publications

13

Citations

1

H-Index

2022

Active since

Affiliations

National Cancer Institute(Current)

N. Ngoi is an author at National Cancer Institute specializing in cancer therapeutics, oncology, and tumor biology.

Top concepts

Publications per year

2022–2022

1

Publications

1

NCI10329: Phase Ib Sequential Trial of Agents against DNA Repair (STAR) Study to investigate the sequential combination of the Poly (ADP-Ribose) Polymerase inhibitor (PARPi) olaparib (ola) and WEE1 inhibitor (WEE1i) adavosertib (ada) in patients (pts) with DNA Damage Response (DDR)-aberrant advanced tumors, enriched for BRCA1/2 mutated and CCNE1 amplified cancers

T.A. Yap, N. Ngoi, E.E. Dumbrava et al. · European Journal of Cancer · 2022 · 13 citations

, , +7

Rows per page

1–1 of 1